Dr. Osman discusses a patient case study highlighting the use of BTK inhibitors for CLL management
Dr. Hani Osman, UAE
Edit Video Component
Dr. Hani Osman, Consultant Haematologist, Tawam Hospital, United Arab Emirates, speaks about the CLL Management in Clinic and provides the following details:
• Details about the case report of relapsed CLL patient’s journey from his clinic.
• Discusses patient’s initial treatment with first generation BTK inhibitor ibrutinib and development of intolerable side effects.
Patient later being shifted to second generation BTK inhibitor based on NCCN recommendations.
Explore more videos
Configure Image Component
Translating Data Into Clinical Practice
Dr. Abdulkareem Algarni, KSA
Configure Image Component
Critical Evaluation of BTKis in CLL
Dr. George Follows, UK
Configure Image Component
Evolvement of CLL Management
Dr. Mahmoud Marashi, UAE
Modal Window Component Section Begins
Modal Window Component Section Ends